What Researchers Did
Researchers investigated the effects of hyperbaric oxygen therapy (HBOT) on plasma antioxidant response, endothelin-1, Interleukine-6 (IL-6), and vascular endothelial growth factor (VEGF) in patients with chronic wounds.
What They Found
Plasma catalase activity significantly increased after the first and fifth HBOT sessions, while myeloperoxidase activity decreased. Endothelin-1 levels progressively decreased, becoming significant at session 20, and plasma malondialdehyde concentration was significantly reduced at the last session. These changes, along with increased VEGF and IL-6, suggest HBOT enhanced antioxidant defenses and stimulated healing.
What This Means for Canadian Patients
Canadian patients with chronic wounds might benefit from hyperbaric oxygen therapy as a treatment option to enhance their body's natural healing mechanisms. This therapy could potentially accelerate wound closure by improving antioxidant defenses, blood vessel formation, and regulating vascular tone.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada or with Canadian participants.
Study Limitations
The abstract does not explicitly state study limitations, but a potential limitation could be the absence of a control group for comparison.